Repligen (RGEN) Interest & Investment Income (2010 - 2026)
Repligen (RGEN) reported Interest & Investment Income of $6.3 million for Q1 2026, down 13.29% year-over-year from $7.3 million in Q1 2025, and down 6.1% quarter-over-quarter from $6.8 million in Q4 2025.
Repligen (RGEN) Interest & Investment Income (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Interest & Investment Income data on file, last reported at $6.3 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $6.3 million, down 13.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $26.6 million (down 22.1% YoY), and the FY2025 annual result was $27.6 million, down 23.04% from the prior year.
- Interest & Investment Income fell to $6.3 million in Q1 2026 per RGEN's latest filing, from $6.8 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $9.4 million in Q2 2024 and troughed at $77000.0 in Q1 2022.
- A 5-year average of $5.9 million and a median of $6.6 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 10197.44% in 2022, then sank 30.03% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $4.0 million in 2022, then jumped by 49.98% to $6.0 million in 2023, then soared by 37.69% to $8.3 million in 2024, then retreated by 18.56% to $6.8 million in 2025, then retreated by 6.1% to $6.3 million in 2026.
- Business Quant data shows RGEN's Interest & Investment Income at $6.3 million in Q1 2026, $6.8 million in Q4 2025, and $6.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | 6.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.34 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 6.92 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Mar 31, 2025 | 7.31 Mn |
| Dec 31, 2024 | 8.29 Mn |
| Sep 30, 2024 | 9.13 Mn |
| Jun 30, 2024 | 9.41 Mn |
| Mar 31, 2024 | 8.99 Mn |
| Dec 31, 2023 | 6.02 Mn |
| Sep 30, 2023 | 6.66 Mn |
| Jun 30, 2023 | 5.96 Mn |
| Mar 31, 2023 | 5.49 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 2.18 Mn |
| Jun 30, 2022 | 708,000.00 |
| Mar 31, 2022 | 77,000.00 |
| Dec 31, 2021 | 39,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 41,000.00 |